TLR4 inhibition blocks PSAP-driven proliferation in gliomas, and inhibiting the PSAP/TGF-β1/Smad axis suppresses invasive growth in glioblastoma, and modulating PSAP expression enhances CD8+ T-cell responses against pancreatic cancer. Here, PSAP is linked to glioma.